Rachel Cant

Rachel Cant

University of Manchester - Manchester / United Kingdom
Medical and Health Sciences / Immunology
AD Scientific Index ID: 1228497
person_outline Rachel Cant's MOST POPULAR ARTICLES
1-) Interleukin-6 (IL-6) trans signaling drives a STAT3-dependent pathway that leads to hyperactive transforming growth factor-β (TGF-β) signaling promoting SMAD3 activation and …S O\\\\\\\'Reilly, M Ciechomska, R Cant, JM van LaarJournal of Biological Chemistry 289 (14), 9952-9960, 20142042014
2-) Interleukin‐6: a new therapeutic target in systemic sclerosis?S O\\\\\\\'reilly, R Cant, M Ciechomska, JM Van LaarClinical & translational immunology 2 (4), e4, 2013932013
3-) Interleukin-6, its role in fibrosing conditionsS O’Reilly, M Ciechomska, R Cant, T Hügle, JM van LaarCytokine & growth factor reviews 23 (3), 99-107, 2012892012
4-) Serum amyloid A induces interleukin‐6 in dermal fibroblasts via Toll‐like receptor 2, interleukin‐1 receptor‐associated kinase 4 and nuclear factor‐κBS O\'reilly, R Cant, M Ciechomska, J Finnigan, F Oakley, S Hambleton, ...Immunology 143 (3), 331-340, 2014722014
5-) Naltrexone Inhibits IL-6 and TNFα Production in Human Immune Cell Subsets following Stimulation with Ligands for Intracellular Toll-Like ReceptorsR Cant, AG Dalgleish, RL AllenFrontiers in immunology 8, 809, 2017682017